Inovio Pharma (INO) Announces $5M Bill & Melinda Gates Foundation Grant for COVID-19 Vaccine Smart Delivery Device

Go back to Inovio Pharma (INO) Announces $5M Bill & Melinda Gates Foundation Grant for COVID-19 Vaccine Smart Delivery Device

Inovio Pharma (INO) Misses Q4 EPS by 14c, Revenues Miss

March 12, 2020 4:30 PM EDT

Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($0.38), $0.14 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $279 thousand versus the consensus estimate of $2.32 million.

Dr. J. Joseph Kim, INOVIO's President & CEO, said, "The company remains well-positioned for 2020 to be a transformational year for INOVIO. Following our very encouraging, albeit... More